News
In the latest twist in the ocean of Zantac-related litigation playing out across state courts, drugmakers have notched a key ...
Digital technology may be on the verge of ‘breaking out’ for schizophrenia treatment, but numerous questions will need to be ...
Delaware's Supreme Court sides with drugmakers including GSK (GSK) and Pfizer (PFE), rejecting expert testimony linking ...
Most symptoms after stopping antidepressants are mild and don’t meet criteria for severe discontinuation syndrome, suggesting ...
The Delaware Supreme Court rejected the legitimacy of expert testimony linking the heartburn drug Zantac to cancer, in a major win for makers of the product.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results